These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29329582)

  • 1. When do patient reported quality of life indicators become prognostic in breast cancer?
    Lee CK; Hudson M; Simes J; Ribi K; Bernhard J; Coates AS
    Health Qual Life Outcomes; 2018 Jan; 16(1):13. PubMed ID: 29329582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group.
    Coates AS; Hürny C; Peterson HF; Bernhard J; Castiglione-Gertsch M; Gelber RD; Goldhirsch A
    J Clin Oncol; 2000 Nov; 18(22):3768-74. PubMed ID: 11078489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group.
    Coates A; Gebski V; Signorini D; Murray P; McNeil D; Byrne M; Forbes JF
    J Clin Oncol; 1992 Dec; 10(12):1833-8. PubMed ID: 1453197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of quality-of-life scores: preliminary results of an analysis of patients with breast cancer.
    Shimozuma K; Sonoo H; Ichihara K; Tanaka K
    Surg Today; 2000; 30(3):255-61. PubMed ID: 10752779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of quality of life in a community sample of patients with early stage breast cancer.
    Walker MS; Schwartzberg LS; Stepanski EJ; Fortner BV
    Breast Cancer Res Treat; 2009 May; 115(2):415-22. PubMed ID: 19373552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in health-related quality of life may predict recurrent breast cancer.
    Kenne Sarenmalm E; Odén A; Ohlén J; Gaston-Johansson F; Holmberg SB
    Eur J Oncol Nurs; 2009 Dec; 13(5):323-9. PubMed ID: 19596212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading.
    Guerra E; Cimadamore A; Simeone P; Vacca G; Lattanzio R; Botti G; Gatta V; D'Aurora M; Simionati B; Piantelli M; Alberti S
    BMC Cancer; 2016 Aug; 16():649. PubMed ID: 27538498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic role of quality of life assessment in breast cancer.
    Staren ED; Gupta D; Braun DP
    Breast J; 2011; 17(6):571-8. PubMed ID: 21895846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer.
    Buccheri GF; Ferrigno D; Tamburini M; Brunelli C
    Lung Cancer; 1995 Mar; 12(1-2):45-58. PubMed ID: 7600030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group.
    Bernhard J; Hürny C; Coates AS; Peterson HF; Castiglione-Gertsch M; Gelber RD; Goldhirsch A; Senn HJ; Rudenstam CM
    Ann Oncol; 1997 Sep; 8(9):825-35. PubMed ID: 9358933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG).
    Bernhard J; Hürny C; Coates AS; Peterson HF; Castiglione-Gertsch M; Gelber RD; Galligioni E; Marini G; Thürlimann B; Forbes JF; Goldhirsch A; Senn HJ; Rudenstam CM
    Br J Cancer; 1998 Sep; 78(5):686-93. PubMed ID: 9744512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer.
    Lee CK; Stockler MR; Coates AS; Gebski V; Lord SJ; Simes RJ;
    Br J Cancer; 2010 Apr; 102(9):1341-7. PubMed ID: 20389302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?
    Bernhard J; Thürlimann B; Schmitz SF; Castiglione-Gertsch M; Cavalli F; Morant R; Fey MF; Bonnefoi H; Goldhirsch A; Hürny C
    J Clin Oncol; 1999 Jun; 17(6):1672-9. PubMed ID: 10561203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of health-related quality-of-life parameters in early-stage breast cancer: an 8-year follow-up study.
    Bredal IS; Sandvik L; Karesen R; Ekeberg O
    Psychooncology; 2011 Oct; 20(10):1102-7. PubMed ID: 20737644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.
    Quinten C; Martinelli F; Coens C; Sprangers MA; Ringash J; Gotay C; Bjordal K; Greimel E; Reeve BB; Maringwa J; Ediebah DE; Zikos E; King MT; Osoba D; Taphoorn MJ; Flechtner H; Schmucker-Von Koch J; Weis J; Bottomley A;
    Cancer; 2014 Jan; 120(2):302-11. PubMed ID: 24127333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
    Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
    Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma.
    Coates A; Thomson D; McLeod GR; Hersey P; Gill PG; Olver IN; Kefford R; Lowenthal RM; Beadle G; Walpole E
    Eur J Cancer; 1993; 29A(12):1731-4. PubMed ID: 8398303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.